Skip to main content

Table 1 Demographic and clinical characteristics of Covid-19 patients admitted to a treatment centre in the Arsi Zone, 2020–2021

From: Evaluation of health-related quality of life of Covid-19 patients: a hospital-based study in South Central Ethiopia

Demographic and clinical characteristics Frequency (%)
Sex
 Female 159 (40.0)
 Male 239 (60.0)
Age (mean = 41.5 (SD: 18.8)
 0–24 years 83 (20.9)
 25–34 102 (25.6)
 35–44 52 (13.1)
 45–54 46 (11.6)
 55 years and above 115 (28.9)
Residence
 Rural 156 (39.0)
 Urban 242 (61.0)
Health status on admission
 Asymptomatic 95 (23.9)
 Mild 93 (23.4)
 Moderate 80 (20.0)
 Severe 130 (32.7)
Comorbidity
 Yes 179 (45.0)
 No 219 (55.0)
Type of comorbidity
 Diabetes mellitus 68 (17.1)
 Hypertension 41 (10.3)
 Asthma 33 (8.3)
 Chronic pulmonary disease 30 (7.5)
 Chronic cardiac diseases 23 (5.8)
 Malignancy 11 (2.8)
 Chronic kidney disease 7 (1.8)
 HIV/AIDS 6 (1.5)
Types of antibiotic administered
 Azithromycin only 148 (37.2)
 Azithromycin + ceftriaxone 131 (32.9)
 Azithromycin + vancomycin + ceftazidime 50 (12.6)
 Azithromycin + ceftriaxone + metronidazole 30 (7.5)
 Azithromycin + ceftriaxone + vancomycin 24 (6.0)
 Azithromycin + ceftriaxone + amoxicillin 13 (3.3)
 Azithromycin + ceftriaxone + ceftazidime 2 (0.5)
Dexamethasone used
 Yes 116 (29.1)
 No 282 (70.9)
Intranasal oxygen used
 Yes 162 (59.3)
 No 236 (40.7)
Length of hospital stay (mean = 14.3 SD:4.8)
 1–7 days 12 (3.0)
 8–14 days 248 (61.8)
 15–21 days 113 (28.4)
 22–28 days 13 (3.3)
 More than 28 days 14 (5.5)